Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000411247 | SCV000486300 | likely pathogenic | Ataxia-telangiectasia syndrome | 2016-05-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000411247 | SCV001419068 | pathogenic | Ataxia-telangiectasia syndrome | 2021-01-02 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser2389*) in the ATM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ATM are known to be pathogenic (PMID: 23807571, 25614872). This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with autosomal recessive ataxia-telangiectasia (PMID: 23807571). In at least one individual the data is consistent with the variant being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 370874). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV004567881 | SCV005057042 | pathogenic | Familial cancer of breast | 2024-01-27 | criteria provided, single submitter | clinical testing |